Skip to content

Clinical trials

Phase 3 Epilepsy trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 3 Country / region: Finland Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20054
20063
20071
20083
20101
20112
20121
20161
20171
20191
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma6
Eisai Limited2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
UCB BIOSCIENCES GmbH2
Xenon Pharmaceuticals Inc.2
Eisai Inc.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Longboard Pharmaceuticals1
Novartis Pharmaceuticals1
UCB BIOSCIENCES, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy22
Seizures8
Epilepsies, Partial3
Drug Resistant Epilepsy1
Epilepsies, Myoclonic1
Headache1
Migraine Disorders1
Neurodevelopmental Disorders1
Recurrence1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.